News
Category
-
PR Newswire
Farapulse Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
January 29, 2021 -
Business Wire
SonderMind Adds Chief Financial and Chief Product Officer to Senior Management Team
January 28, 2021 -
GlobeNewswire
Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less
January 28, 2021 -
PR Newswire
Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)
January 27, 2021 -
PR Newswire
Benchling Launches Validated Cloud to Accelerate Product Development for Life Sciences
January 26, 2021 -
PR Newswire
Hurdle Raises $5 Million Series Seed to Accelerate Expansion of its Mental Health Platform with Special Focus on the Black Community
January 25, 2021 -
GlobeNewswire
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX701, a New Gene Therapy for the Treatment of Wilson Disease
January 21, 2021 -
FierceBiotech
Rallybio hires Tuch from BMO to lead corporate development
January 21, 2021 -
PR Newswire
Avidity Biosciences Appoints W. Michael Flanagan, Ph.D. as Chief Technical Officer
January 21, 2021 -
PR Newswire
Iora Health Strengthens Executive Team with CFO and CGO Hires
January 20, 2021 -
Business Wire
Turnstone Biologics Acquires Novel Cell Therapy Platform
January 20, 2021 -
GlobeNewswire
Acacia Pharma wins BEL Small Company of the Year for the second consecutive year
January 20, 2021 -
FierceBiotech
Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer
January 20, 2021 -
GlobeNewswire
Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
January 19, 2021 -
Business Wire
Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
January 19, 2021 -
GlobeNewswire
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
January 19, 2021 -
PR Newswire
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia
January 18, 2021 -
PR Newswire
Notable Health First to Launch Automated Identification and Engagement of Patients Eligible for COVID-19 Vaccine
January 14, 2021 -
Business Wire
Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month
January 14, 2021 -
Business Wire
Novaerus Defend 1050 Cleared by FDA as 510(k) Class II Medical Device to Inactivate and Filter Out Airborne Virus and Bacteria for Medical Purposes
January 14, 2021 -
PR Newswire
Benchling Doubles Annual Recurring Revenue (ARR) for Fourth Straight Year Amid COVID-19 Pandemic
January 14, 2021 -
GlobeNewswire
Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD)
January 14, 2021 -
Endpoints News
Adaptimmune ‘ready for primetime’ as it prepares to launch T cell therapy for sarcoma, CEO Adrian Rawcliffe says
January 13, 2021 -
BioSpace
Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO
January 13, 2021 -
PR Newswire
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
January 12, 2021 -
FierceBiotech
Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
January 12, 2021 -
PR Newswire
OTA Insight Announced Winner Of Three 2021 HotelTechAwards Categories
January 12, 2021 -
GlobeNewswire
Adagene Announces Milestone of CAR-T Collaboration with the National Heart, Lung, and Blood Institute at the National Institutes of Health
January 12, 2021 -
PR Newswire
Centivo Expands Health Partnerships in New York and New Jersey
January 12, 2021 -
FierceBiotech
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
January 11, 2021 -
GlobeNewswire
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications
January 11, 2021 -
PR Newswire
Avidity Biosciences Announces Changes to its Board of Directors
January 11, 2021 -
GlobeNewswire
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
January 11, 2021 -
GlobeNewswire
Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors
January 11, 2021 -
PR Newswire
Whatfix Achieves Rapid Growth in 2020, Drives 150% Increase in Usage of In-App Engagement for Enterprise Customers
January 8, 2021 -
PR Newswire
Sana Biotechnology Announces Appointments to its Board of Directors
January 8, 2021 -
PR Newswire
Avidity Biosciences Announces 2021 Pipeline Updates and Research Collaboration with MyoKardia
January 8, 2021 -
GlobeNewswire
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in Neurodegeneration
January 8, 2021 -
Business Insider
RightHand Robotics director of product management explains why automation is no longer a choice, it’s a necessity
January 8, 2021 -
GlobeNewswire
Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
January 7, 2021 -
GlobeNewswire
Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors
January 7, 2021 -
PR Newswire
Sana Biotechnology Builds Key Regulatory Capabilities as Ke Liu, M.D., Ph.D., Joins Senior Leadership Team
January 6, 2021 -
PR Newswire
Cigna Adds Iora Health to Growing Medicare Advantage Network
January 6, 2021 -
Business Wire
CoinDesk Acquires TradeBlock, the World’s Leading Crypto Index Provider
January 5, 2021 -
PR Newswire
Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
January 4, 2021 -
PR Newswire
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma
December 27, 2020 -
GlobeNewswire
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
December 21, 2020 -
PR Newswire
FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval
December 17, 2020 -
Business Wire
Kyruus and HealthSparq Come Together to Transform Care Navigation Through Novel Payer-Provider Collaboration
December 17, 2020 -
Endpoints News
GlaxoSmithKline plumbs the discovery field (again), betting up to $815M for the latest add-on to its oncology pipeline
December 17, 2020 -
PR Newswire
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
December 17, 2020 -
Business Wire
NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020 -
Crunchbase
Mozper Banks $3.55M To Develop Debit Card, App For LatAm Children
December 14, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
December 10, 2020 -
GlobeNewswire
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
December 9, 2020 -
PR Newswire
Vestwell Partners with Envestnet to Offer Turnkey Retirement Plan Solutions to Industry Advisors
December 9, 2020 -
GlobeNewswire
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
December 8, 2020 -
GlobeNewswire
Flywire Reports Record Growth for Digital Healthcare Payments Platform
December 8, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
December 8, 2020 -
Crunchbase
Centivo Secures $34M Series B To Scale Self-funded Employer Health Plan
December 7, 2020 -
PR Newswire
Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
December 7, 2020 -
GlobeNewswire
Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
December 4, 2020 -
GlobeNewswire
Adagene Announces Expansion of Leadership Team to Support Strategic Growth
December 2, 2020 -
Business Wire
ConnexPay Raises Additional Funding to Propel Adoption of Payments Technology
December 1, 2020 -
Business Wire
Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating RIVAL-01 For the Treatment of Solid Tumors
December 1, 2020 -
PR Newswire
OTA Insight Announces Atomize is First RMS to Ingest Company’s Revolutionary New Forward-Looking Data Sets
December 1, 2020 -
PR Newswire
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
December 1, 2020 -
PR Newswire
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
November 22, 2020 -
FierceBiotech
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
November 20, 2020 -
GlobeNewswire
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
November 19, 2020 -
PR Newswire
Toast Leadership Team Named Entrepreneur Of The Year® 2020 National Overall Award Winner
November 19, 2020 -
Business Wire
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
November 18, 2020 -
GlobeNewswire
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH
November 16, 2020 -
PR Newswire
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
November 15, 2020 -
GlobeNewswire
Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
November 13, 2020 -
GlobeNewswire
Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia at AASLD
November 13, 2020 -
Business Wire
Xilio Therapeutics Presents Promising Preclinical Tumor-Selective Efficacy and Safety Data for XTX201 (IL-2) and XTX101 (anti-CTLA-4) at SITC
November 12, 2020 -
PR Newswire
Whatfix To Host Second Virtual Digital Adoption Conference
November 10, 2020 -
Business Wire
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 10, 2020 -
PR Newswire
PatientPing Partners with MedAllies to Ensure Hospital Partners’ Compliance with CMS E-Notifications Condition of Participation
November 10, 2020 -
GlobeNewswire
Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (TV) Technology Achieved in Phase 1/2 Study of ETV:IDS (DNL310) in Hunter Syndrome (MPS II)
November 10, 2020 -
PR Newswire
Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
November 10, 2020 -
GlobeNewswire
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
November 9, 2020 -
PR Newswire
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
November 9, 2020 -
GlobeNewswire
Beam Therapeutics Names First CAR-T Base Editing Development Candidate for the Treatment of T-ALL and Presents New Data at SITC 2020
November 9, 2020 -
GlobeNewswire
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
November 5, 2020 -
GlobeNewswire
Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020
November 4, 2020 -
PR Newswire
Sana Biotechnology Announces Acquisition of Oscine
October 30, 2020 -
Endpoints News
Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem
October 28, 2020 -
Crunchbase
French Scale-up Odaseva Raises $25M To Continue Global Expansion
October 27, 2020